Autoantibodies in Systemic Lupus Erythematosus: Diagnostic and Pathogenic Insights
Journal of Clinical Medicine · 12.08.2025 · 14 (16) · 5714
DOI: 10.3390/jcm14165714 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 12.08.2025. Verfasst von Eleni Pagkopoulou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Fourth Department of Internal Medicine, Hippokration Hospital, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by widespread immune dysregulation and the production of autoantibodies targeting nuclear, cytoplasmic, and cell surface antigens. These autoantibodies are central to disease pathogenesis, contribute to immune complex formation and organ damage, and serve as essential diagnostic and prognostic markers. Their detection supports disease classification, guides clinical decision-making, and offers insight into disease activity and therapeutic response. Traditional markers such as anti-nuclear antibodies (ANA), anti-dsDNA, and anti-Sm antibodies remain diagnostic cornerstones, but growing attention is given to anti-C1q, anti-nucleosome antibodies (ANuA), anti-ribosomal P, antiphospholipid, and anti-cytokine antibodies due to their associations with specific disease phenotypes and activity. These markers may reflect disease activity, specific organ involvement, or predict flares. The mechanisms underlying their persistence include B cell tolerance failure and long-lived plasma cell activity. The aim of this review is to summarize current knowledge on the major autoantibodies in SLE, appraise available detection methods, highlight their clinical utility and limitations and present evidence on the association between antibodies and disease phenotypes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Fourth Department of Internal Medicine, Hippokration Hospital, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece.
- First Department of Urology, G. Gennimatas Hospital, Aristotle University of Thessaloniki, 54635 Thessaloniki, Greece.
- Laboratory of Biological Chemistry, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
- 1st Department of Nephrology, Hippokration Hospital, School of Medicine, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece.
ORCID-Profile: Eleni Pagkopoulou, Charalampos Loutradis, Maria Papaioannou, Maria Stangou
Zitieren
APA
Pagkopoulou, E., Loutradis, C., Papaioannou, M., Daoudaki, M., Stangou, M., & Dimitroulas, T. (2025). Autoantibodies in Systemic Lupus Erythematosus: Diagnostic and Pathogenic Insights. Journal of Clinical Medicine, 14(16), 5714. https://doi.org/10.3390/jcm14165714
Vancouver
Pagkopoulou E, Loutradis C, Papaioannou M, Daoudaki M, Stangou M, Dimitroulas T. Autoantibodies in Systemic Lupus Erythematosus: Diagnostic and Pathogenic Insights. Journal of Clinical Medicine. 2025;14(16):5714. doi:10.3390/jcm14165714
BibTeX
@article{Pagkopoulou2025,
author = {Pagkopoulou, Eleni and Loutradis, Charalampos and Papaioannou, Maria and Daoudaki, Maria and Stangou, Maria and Dimitroulas, Theodoros},
title = {Autoantibodies in Systemic Lupus Erythematosus: Diagnostic and Pathogenic Insights},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {16},
pages = {5714},
doi = {10.3390/jcm14165714}
}
EUVIMED